{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:01:25Z","timestamp":1780297285417,"version":"3.54.0"},"reference-count":24,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Appl Thromb Hemost"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Dysregulation of the coagulation and fibrinolytic systems has been closely linked to cancer progression and metastasis. This study investigated whether the coagulation- and fibrinolysis-related biomarkers, TAT, PIC, TM, and tPAIC, are correlated with cancer metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma levels of TAT, PIC, TM, and tPAIC were measured in 240 treatment-naive patients with lung, ovarian, breast, or colorectal cancer and 120 healthy individuals. Participants were categorized into metastasis, non-metastasis and healthy groups based on clinical evaluation and imaging results. Statistical analysis and ROC curves were used to assess the performance of individual and combined biomarkers in detecting metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All four biomarkers were significantly elevated in patients with metastasis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001). In multivariate logistic regression analysis, PIC demonstrated the strongest association with metastasis. ROC curve analysis revealed that in lung cancer patients, a parallel test of TAT and PIC achieved a sensitivity of 93.33% and an NPV of 88.24%. In ovarian cancer, a serial test of TAT, PIC, and TM achieved a specificity of 80.00% and a PPV of 75.00%. In breast cancer, a parallel test of TAT, PIC, and tPAIC yielded a sensitivity of 93.33% and an NPV of 89.47%. In colorectal cancer, a parallel test of all four markers achieved a sensitivity of 96.67% and an NPV of 93.75%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Distinct combinations of coagulation and fibrinolysis biomarkers demonstrate high diagnostic performance for detecting metastasis across different cancer types. Tailoring biomarker panels according to cancer type may provide significant clinical value in monitoring and predicting cancer metastasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10760296261438236","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:17:42Z","timestamp":1780057062000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Value of Coagulation-Fibrinolysis Biomarkers for Metastasis in Lung, Ovarian, Breast, and Colorectal Cancers"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6710-5390","authenticated-orcid":false,"given":"Yumei","family":"Zhao","sequence":"first","affiliation":[{"name":"National Center for Human Genetic Resources, National Research Institute for Health and Family Planning"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1586-3816","authenticated-orcid":false,"given":"Xinping","family":"Sun","sequence":"additional","affiliation":[{"name":"Laboratory Department, Peking University International Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3878-8514","authenticated-orcid":false,"given":"Bozhi","family":"Lin","sequence":"additional","affiliation":[{"name":"Laboratory Department, Peking University International Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8757-5882","authenticated-orcid":false,"given":"Shiyuan","family":"Xu","sequence":"additional","affiliation":[{"name":"National Center for Human Genetic Resources, National Research Institute for Health and Family Planning"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9332-9644","authenticated-orcid":false,"given":"Huafang","family":"Gao","sequence":"additional","affiliation":[{"name":"National Center for Human Genetic Resources, National Research Institute for Health and Family Planning"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-016-2279-0"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01195-4"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118031"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00682.x"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e3283610381"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10106-4"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13552"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0434"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature19076"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1776875"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1688495"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-019-09802-8"},{"issue":"2","key":"e_1_3_3_14_2","first-page":"113","article-title":"The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression","volume":"17","author":"Ko\u0142odziejczyk J","year":"2013","unstructured":"Ko\u0142odziejczyk J, Ponczek MB. The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemp Oncol (Pozn). 2013;17(2):113-119.","journal-title":"Contemp Oncol (Pozn)"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<555::AID-IJC18>3.0.CO;2-H"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.3021"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2012.10.003"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1553"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13194"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.05.105"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1163-4"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051384"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000035"},{"issue":"1","key":"e_1_3_3_24_2","first-page":"1","article-title":"Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas","volume":"1","author":"Asanuma K","year":"2019","unstructured":"Asanuma K, Nakamura T, Asanuma Y, et al. Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas. Cancer Biomark. 2019;1(1):1-8.","journal-title":"Cancer Biomark"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-024-00850-9"}],"container-title":["Clinical and Applied Thrombosis\/Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296261438236","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10760296261438236","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296261438236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T06:16:33Z","timestamp":1780294593000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10760296261438236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"alternative-id":["10.1177\/10760296261438236"],"URL":"https:\/\/doi.org\/10.1177\/10760296261438236","relation":{},"ISSN":["1076-0296","1938-2723"],"issn-type":[{"value":"1076-0296","type":"print"},{"value":"1938-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"10760296261438236"}}